Enzalutamid Pharmascience

Enzalutamide is a medication used to treat certain types of cancer. This oral medication is manufactured by Pharmascience International Ltd and is available in the EU market.

Enzalutamide is primarily used in the management of advanced prostate cancer. It works by blocking the effects of androgens, which are hormones that can promote the growth of cancer cells. This medication is often prescribed for patients who have not responded to other treatments. Enzalutamide is designed for oral use and is intended to be taken as directed by a healthcare professional.

Common effects of Enzalutamide may include fatigue, hot flashes, and joint pain. Some individuals may also experience dizziness or headaches. It is important to note that not everyone will experience these effects, and they can vary in severity. If any effects are severe or persistent, it is advisable to consult a healthcare provider.

Enzalutamide should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should exercise caution, as Enzalutamide may have adverse effects on fetal development.

Enzalutamide may interact with certain medications, including those that are metabolized by the liver. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Patients should also be cautious when taking other medications that affect hormone levels. Always consult a healthcare provider before starting or stopping any medication.